A diffuse large B-cell lymphoma that is localized to the lungs at the time of presentation. Signs and symptoms include cough, dyspnea, and hemoptysis.
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 4 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning primary pulmonary diffuse large B-cell lymphoma
Updated Feb 9, 2026
A recent study highlights the diagnostic challenges posed by benign thyroid nodules that can mimic residual disease in patients with concurrent thyroid and gastric diffuse large B-cell lymphoma. The research emphasizes the importance of ultrasound-guided biopsy for accurate diagnosis.
A recent study highlights primary pulmonary MALT lymphoma as a rare condition often misdiagnosed due to its pneumonic presentation. This research underscores the need for increased awareness and accurate diagnosis of this rare lymphoma subtype.
A new study explores the link between breast implants and Epstein-Barr virus-positive diffuse large B-cell lymphoma. This research highlights potential risks associated with breast implants, contributing to the understanding of this rare lymphoma subtype.